Granahan Investment Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Granahan Investment Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,081	Closed	-$307K	–	214
2020 Q4	$307K	Sell	5,081 -551	-10%	-$59.7K	0.01%	191
2020 Q3	$750K	Buy	5,632 +99	+2%	+$16.5K	0.03%	170
2020 Q2	$933K	Buy	5,533 +4,497	+434%	+$750K	0.03%	168
2020 Q1	$149K	Sell	1,036 -30	-3%	-$9.18K	0.01%	184
2019 Q4	$352K	Buy	1,066 +122	+13%	+$56K	0.02%	171
2019 Q3	$472K	Buy	944 +17	+2%	+$9.59K	0.03%	170
2019 Q2	$563K	Buy	927 +2	+0.2%	+$1.23K	0.03%	176
2019 Q1	$565K	Sell	925 -45	-5%	-$24.5K	0.03%	183
2018 Q4	$354K	Sell	970 -19	-2%	-$10.2K	0.03%	181
2018 Q3	$668K	Buy	+989	New	+$701K	0.04%	184

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Granahan Investment Management's NBRV Position: Q1 2021 in Review

Granahan Investment Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2021, closing a stake of 5,081 shares — an estimated $307K sold.

Granahan Investment Management first reported a position in NBRV in Q3 2018 and held it in 10 quarters. The position peaked at $933K in Q2 2020. 33 funds tracked by Wall St. Rank hold NBRV as of Q1 2021.

Granahan Investment Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2021 after selling out during the quarter.
Granahan Investment Management sold 5,081 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2021, an estimated $307K.
Granahan Investment Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and held it in 10 quarters.
Granahan Investment Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $933K in Q2 2020.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2021.

Based on Granahan Investment Management's 13F filing for Q1 2021, filed 17 May 2021.